Progression of SARS-CoV-2 seroprevalence in St. Louis, Missouri, through January 2021

Authors

Brittany K Smith, Washington University School of Medicine in St. Louis
Andrew B Janowski, Washington University School of Medicine in St. Louis
Arim C Fremont, Washington University School of Medicine in St. Louis
Lucas J Adams, Washington University School of Medicine in St. Louis
Ya-Nan Dai, Washington University School of Medicine in St. Louis
Christopher W Farnsworth, Washington University School of Medicine in St. Louis
Ann M Gronowski, Washington University School of Medicine in St. Louis
Stephen M Roper, Washington University School of Medicine in St. Louis
David Wang, Washington University School of Medicine in St. Louis
Daved H Fremont, Washington University School of Medicine in St. Louis

Journal

mSphere

Publication Date

8-25-2021

Volume

6

Issue

4

First Page

e0045021

Document Type

Open Access Publication

DOI

10.1128/mSphere.00450-21

Rights and Permissions

Smith BK, Janowski AB, Fremont AC, Adams LJ, Dai Y-N, Farnsworth CW, Gronowski AM, Roper SM, Wang D, Fremont DH. 2021. Progression of SARS-CoV-2 seroprevalence in St. Louis, Missouri, through January 2021. mSphere 6:e00450-21. https://doi.org/10.1128/ mSphere.00450-21. © 2021 Smith et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Recommended Citation

Smith, Brittany K; Janowski, Andrew B; Fremont, Arim C; Adams, Lucas J; Dai, Ya-Nan; Farnsworth, Christopher W; Gronowski, Ann M; Roper, Stephen M; Wang, David; and Fremont, Daved H, "Progression of SARS-CoV-2 seroprevalence in St. Louis, Missouri, through January 2021." mSphere. 6, 4. e0045021 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11333